iShares Biotechnology ETF

IBB · ETF

$207.74−$1.80 (−0.86%)TodayMarket closed ·
Prev close $209.54

About IBB

IBB was created on 2001-02-05 by iShares. The fund's investment portfolio concentrates primarily on health care equity. The ETF currently has 10778.45m in AUM and 237 holdings. IBB tracks the performance of a modified market-cap-weighted index of US biotechnology companies listed on US exchanges.

Issuer
iShares
Tracks
NYSE Biotechnology (TR)
Expense ratio
0.44%
Assets under management
$11.01B
Inception
Feb 5, 2001
Asset class
Equity

IBB key statistics

Market cap
0
Price-earnings ratio
0.00
Average volume
1.74M
Volume
830.36K
Open price
$208.44
High today
$208.71
Low today
$205.96
52 Week high
$217.12
52 Week low
$153.50

iShares Biotechnology ETF (IBB) at a glance

iShares Biotechnology ETF (IBB) last traded at $207.74, with a market cap of 0 and a price-to-earnings ratio of 0.00.

Today the fund has traded between $205.96 and $208.71. The current price is 0.9% above the day's low and 0.5% below its high.

Volume so far is 830.36K shares, below the average of 1.74M shares a day.

Over the past year iShares Biotechnology ETF has ranged from $153.50 to $217.12, and now sits 85% of the way up that range.

IBB news

  • Reported October 22, U.S. Treasury Department Issues Notice Of Proposed Rulemaking For The Outbound Investment Security Program Under The COINS Act; Secretary Has Added Biotechnology To Proposed Regulations

  • Piero Cingari

    Dow Jones Climbs to 52,000 While Chips Bleed on Rate-Hike Fears: Stock Market Today

  • Piero Cingari

    Stock Market Today: S&P 500, Russell 2000 Fall as 30-Year Yield Hits 5.7%

  • Piero Cingari

    S&P 500 Erases Losses as US, Iran Reportedly Discuss Hormuz Deal: Stock Market Today

  • Piero Cingari

    Nasdaq 100 Flirts with Records, Oil Sinks for Fifth Day: Stock Market Today

  • Piero Cingari

    Nasdaq 100 Rallies as Oil Slides, Yields Retreat: Stock Market Today

  • Piero Cingari

    S&P 500 Gains, Crude Falls Ahead Of Fed's Expected First Hike Since 2023: Stock Market Today

  • Piero Cingari

    QUICK SPARK: Amgen Stock Eyes Worst Day Since October 2000

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.